3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain
- 1 June 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 137 (2-3), 265-268
- https://doi.org/10.1016/0014-2999(87)90233-0
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainEuropean Journal of Pharmacology, 1986
- Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogueEuropean Journal of Pharmacology, 1986
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve TerminalsScience, 1985
- Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamineNeuropharmacology, 1983
- Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)Journal of Pharmaceutical Sciences, 1980